Psychedelics in the press

Sep 2022

Ketamine: A Promising Novel Therapy for Anxiety and PTSD

Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and post-traumatic stress disorder (PTSD).1,2 Several studies have also found it to be effective for treating suicidal ideation.3,4 “Ketamine can play an important...

Ketamine for Depression: What to Know

By Sonya Collins Medically Reviewed by Dan Brennan, MD on May 04, 2022 Jeff Winograd didn’t know an adult life without depression. Since he was 20 years old, he had tried virtually every antidepressant on the market. But he says, “The depression was just a constant.” By the time he was 45 years...

San Francisco decriminalizes psychedelics

By Max Savage Levenson, 9/7/2022 Last night, Sept. 6, the San Francisco Board of Supervisors gave unanimous approval to a resolution that effectively decriminalizes entheogens and their compounds for adult use. The resolution defines entheogens as the “full spectrum of plants, fungi, and natural materials that can inspire personal and spiritual well-being.”...

Aug 2022

Get Ready for the Magic Mushroom Pill

The medical benefits of psychedelic drugs have gone from Age of Aquarius punchline to solid science, but the startups racing to market might still be getting ahead of themselves. ByKristen V Brown and Drake Bennett - 8/22/2022 Under the pale light of a laboratory flow hood, clad in a cleanroom suit, hat,...

Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows

Psilocybin, the ingredient in magic mushrooms, along with talk therapy, showed significant benefit in the largest clinical trial of its kind. By Kaitlin Sullivan, Akshay Syal, M.D., Kori Lynch and Harry Smith Two doses of psilocybin pills, along with psychotherapy, helped people with alcohol use disorder reduce drinking for at least eight...

Life Support for The Soul

By Black Swan, MD - 7/3/2021 I’m on a plane in a viral pandemic headed for Rythmia, a life advancement center in Costa Rica, to drink the plants. I’m a physician, a specialist in infectious disease (ID), who practices evidenced based medicine and this voyage is therefore wildly atypical. If, as...

Women with PTSD Show Accelerated Cognitive Decline in Midlife

By Jolynn Tumolo - 07/12/2022 Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study published in JAMA Network Open. “Given that cognitive decline is associated with subsequent Alzheimer disease and related dementias, better understanding of this association may be important to...